Asset Dedication’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.64K Hold
37
– – ﹤0.01% 954
2026
Q2
$3.44K Hold
37
– – ﹤0.01% 971
2026
Q1
$3.29K Hold
37
– – ﹤0.01% 913
2025
Q4
$3.52K Hold
37
– – ﹤0.01% 942
2025
Q3
$3.65K Hold
37
– – ﹤0.01% 948
2025
Q2
$3.94K Hold
37
– – ﹤0.01% 962
2025
Q1
$3.37K Sell
37
-4
-10% -$448 ﹤0.01% 912
2024
Q4
$4.67K Hold
41
– – ﹤0.01% 871
2024
Q3
$4.87K Hold
41
– – ﹤0.01% 905
2024
Q2
$3.3K Buy
+41
New +$3.75K ﹤0.01% 1008

Other funds holding BNTX

Asset Dedication's BNTX Position: Q3 2026 in Review

Asset Dedication held its BioNTech (BNTX) position steady in Q3 2026 at 37 shares worth $3.64K. The position accounts for ﹤0.01% of the portfolio, ranked #954.

Asset Dedication first reported a position in BNTX in Q2 2024 and has held it in 10 quarters since. The position peaked at $4.87K in Q3 2024. 223 funds tracked by Wall St. Rank hold BNTX as of Q3 2026.

  • Asset Dedication held 37 shares of BioNTech worth $3.64K as of Q3 2026.
  • Asset Dedication left its BioNTech share count unchanged in Q3 2026.
  • BioNTech made up ﹤0.01% of Asset Dedication's portfolio in Q3 2026, its #954 holding.
  • Asset Dedication first reported a position in BioNTech in Q2 2024 and has held it in 10 quarters since.
  • Asset Dedication's BioNTech position peaked at $4.87K in Q3 2024.
  • 223 funds tracked by Wall St. Rank held BioNTech as of Q3 2026.

Based on Asset Dedication's 13F filing for Q3 2026, filed 3 Nov 2026.